Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34 | $33 | $32 | $32 |
| - Cash | $18 | $21 | $22 | $22 |
| + Debt | $12 | $12 | $11 | $10 |
| Enterprise Value | $28 | $24 | $21 | $20 |
| Revenue | $75 | $76 | $71 | $69 |
| % Growth | -0.7% | 6.7% | 2.6% | – |
| Gross Profit | $13 | $14 | $13 | $13 |
| % Margin | 16.7% | 18.8% | 18.8% | 19.2% |
| EBITDA | $5 | $6 | $6 | $6 |
| % Margin | 6.5% | 8.6% | 8.9% | 8.3% |
| Net Income | $3 | $4 | $4 | $4 |
| % Margin | 3.8% | 5.4% | 5.6% | 5.4% |
| EPS Diluted | 1.74 | 2.49 | 2.44 | 2.29 |
| % Growth | -30.1% | 2% | 6.6% | – |
| Operating Cash Flow | $3 | $4 | $7 | $6 |
| Capital Expenditures | -$1 | -$2 | -$1 | -$1 |
| Free Cash Flow | $2 | $2 | $6 | $4 |